TherapeuticsMD introduces third prescription prenatal vitamin

TherapeuticsMD™, Inc. (OTCQB: TXMD), parent company of vitaMedMD^®, LLC ("vitaMedMD"), a specialty pharmaceutical company ("TherapeuticsMD" or the "Company"), announced that on May 10, 2012 it launched its third prescription prenatal vitamin, vitaMedMD™ RediChew™ Rx, following the successful launch of vitaMedMD™ One Rx earlier this month and vitaMedMD™ Plus Rx last month. vitaMedMD RediChew Rx is a small, vanilla flavored, chewable prenatal vitamin tablet that dissolves quickly and is taken once daily.

Like vitaMedMD Plus Rx and vitaMedMD One Rx, vitaMedMD RediChew Rx contains the same unique combination of folic acid and the patent-protected fourth generation folate, Quatrefolic^®. With the addition of Quatrefolic, all three vitaMedMD Rx prenatal vitamins have the potential to further reduce the devastating impact of folic acid related deficiencies such as spina bifida and anencephaly.

Jason Spitz, Vice President of Marketing for TherapeuticsMD, stated, "vitaMedMD RediChew Rx provides a great option for pregnant women who have difficulty swallowing tablets or capsules, or where nausea or morning sickness make taking tablets or capsules difficult. vitaMedMD RediChew Rx is also a suitable daily multivitamin choice for all women of childbearing age, as it provides the folic acid recommended by the U.S. Public Health Service, CDC, and the March of Dimes. With the addition of Quatrefolic, vitaMedMD prescription prenatals provide a 'body ready' form of folate, which is especially important for women with MTHFR polymorphisms who may not be able to fully metabolize synthetic folic acid. vitaMedMD RediChew Rx also contains vitamins B6 and B12, which may help relieve nausea and morning sickness."